AVR 0.90% $9.91 anteris technologies ltd

Ann: Response to Aware Query, page-78

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 527 Posts.
    lightbulb Created with Sketch. 51
    Burningtiger, the last quote in your post, 'hesitant of the road you see ahead', let me correct the misunderstanding, ADMEDUS is a global company that has put an international management team in place to rival any Bio/Pharma company in their field with Professor Ian Frazer, the king of immunotherapies in his field and Professor Leon Neethling with a breakthrough technology in tissue.

    WP is the master of reorganisation on a global scale, he has taken ADMEDUS from a start-up to a global heavyweight. I say this because not only do I see the difference in AHZ's management but also what is happening in the global management meaning vasculcel has opened up for ADMEDUS on the grounds that Baxter is out, I can't see surgeons using anything else.
    When the 3D Curved Patch comes out it will be a first with no opposition. Now, this is fact and ADMEDUS is ready to take over these markets so please be patient till the end of FY17.

    So, mate, I hope this helps and we will pick up our conversation about WP's salary in just over 2 months so I have the proof before I start talking about it.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$9.91
Change
-0.090(0.90%)
Mkt cap ! $209.4M
Open High Low Value Volume
$10.00 $10.00 $9.65 $70.76K 7.202K

Buyers (Bids)

No. Vol. Price($)
1 300 $9.80
 

Sellers (Offers)

Price($) Vol. No.
$9.91 475 2
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.